Details.
A comprehensive analysis of the coding, coverage and payment mechanisms affecting a medical device or drug's commercial viability in selected countries across the US, Europe and beyond. Deliverables include money flow and financial incentive analysis, relevant reimbursement mechanisms, coding systems, coverage policies, payment rates, potential reimbursement pathways, key stakeholders and decision makers, milestone timelines, and a country-specific initial strategy. The methodology includes interviews with local health economics specialists and practising physicians. Most effective when conducted early to inform product features, applications, intended use and predicate device selection.